One of Wood's favorite AI stocks has been criticized by CNBC host Jim Cramer multiple times in 2025, including this week.

Wedbush ups Palantir’s price target to $160, citing AIP traction. Analyst sees $1B+ revenue from Palantir’s U.S. commercial ...

Estee Lauder (EL) is expected to see a significant turnaround as the Beauty Reimagined strategy takes hold, with a 30% stock ...

Shares of Advanced Micro Devices Inc. (NASDAQ:AMD) are trading higher Thursday afternoon after HSBC upgraded the stock from ...

Xtandi plus leuprolide improved overall survival in prostate cancer patients in the Phase 3 EMBARK trial, with no new safety ...

According to Benzinga Pro, Teva Pharmaceutical Indus's peer group average for short interest as a percentage of float is 3.59 ...

AbbVie licensed IGI's trispecific myeloma drug ISB 2001 in a deal worth up to $1.925 billion following strong early-phase ...

Moderna's Spikevax receives FDA approval for use in high-risk children; Pfizer, BioNTech appeal U.K. ruling in COVID-19 ...

ARK Innovation ETF (BATS: ARKK) is pushing to fresh 52-week highs Thursday, buoyed by strong performances from its key ...

Amazon's Project Kuiper satellite launches have begun, with a target of offering consumer service in late 2025. Analyst ...

Bank of America says SoFi may benefit from student loan reforms, with potential gains in loan volume, fee revenue, and ...

For Ethereum staking, returns may range from 50% to 100% of the official protocol rate, due to the platform's method of ...